Key points
- In a US national survey, 47.1% of adults with ADHD had an anxiety disorder in the past year, compared with 19.5% of adults without ADHD.
- Anxiety was reported by 8% of adults on Adderall XR (vs 5% on placebo), 6% on Vyvanse (vs 0%) and 8% on Concerta (vs 2%) in label trials.
- Anxiety is among the most common reasons for stopping Concerta in its clinical trials, according to the label.
- A meta-analysis of 23 trials in children found less anxiety on stimulants than on placebo, and a 442-person adult trial found atomoxetine improved both ADHD and social anxiety symptoms.
- Amphetamine labels warn of serotonin syndrome with SSRIs and SNRIs, and the Strattera label reports much higher atomoxetine levels with paroxetine or fluoxetine.
People ask about anxiety and ADHD medication from two directions. Some worry a stimulant will make them more anxious. Others have lived with anxiety for years and wonder whether untreated ADHD is part of the reason. Both concerns are reasonable, and the evidence supports parts of each. This page uses FDA labels (checked on DailyMed on October 19, 2026) and published research. It does not give doses and is not advice to start, stop or change a medication.
Anxiety and ADHD often occur together
The National Comorbidity Survey Replication, a nationally representative US study published by Kessler and colleagues in 2006, found that 47.1% of adults with ADHD had an anxiety disorder in the previous 12 months, compared with 19.5% of adults without ADHD. Social phobia, specific phobia, panic disorder, post-traumatic stress disorder and generalized anxiety disorder were all more common in the ADHD group.
That overlap matters for medication. Someone who already has an anxiety disorder may report anxiety on a new medication whether or not the medication caused it. It is also why an adult ADHD evaluation looks at anxiety directly: as another explanation for attention problems, or as something present alongside ADHD. The adult ADHD evaluation page describes how Dr. Shershow's evaluation covers this.
What the labels report
These figures come from each label's placebo-controlled adult trials. The Adderall XR label warns that rates from different drugs' trials cannot be directly compared.
| Medication | Anxiety-related effects in adult trials (drug vs placebo) |
|---|---|
| Adderall XR (amphetamine) | Anxiety 8% vs 5%; agitation 8% vs 5%; nervousness 13% vs 13%. Anxiety led 2.1% of people on the drug to leave the trial. |
| Vyvanse (lisdexamfetamine) | Anxiety 6% vs 0%; feeling jittery 4% vs 0%; agitation 3% vs 0%; restlessness 3% vs 0% |
| Concerta (methylphenidate) | Anxiety 8% vs 2%; irritability 6% vs 1%; restlessness 3% vs 0%; nervousness 3% vs 1%. Anxiety and irritability are among the most common reasons for stopping in its trials. |
| Strattera (atomoxetine) | Irritability 5% vs 3%. The label lists anxiety, agitation and panic attacks among psychiatric symptoms reported with the drug. |
| Qelbree (viloxazine) | Irritability 4% vs 3%. The label names anxiety, agitation and panic attacks among symptoms to watch as possible precursors of suicidal thoughts. |
The stimulant figures are real but modest, and the placebo groups reported anxiety too. Note that the current Concerta label lists only two contraindications: hypersensitivity to methylphenidate and use of an MAOI antidepressant. Anxiety is not among them, though it remains a side effect to watch.
Can ADHD medication reduce anxiety?
Several studies point that way, with limits:
- Children, stimulants. A 2015 meta-analysis by Coughlin and colleagues pooled 23 placebo-controlled trials with 2,959 children. Anxiety was reported less often on stimulants than on placebo (relative risk 0.86). The authors noted this does not rule out increased anxiety in some individuals. These were children, so the result may not carry over to adults.
- Adults, atomoxetine. A 14-week randomized trial by Adler and colleagues (2009) enrolled 442 adults with both ADHD and social anxiety disorder. Atomoxetine improved ADHD symptoms and social anxiety scores more than placebo, with higher rates of insomnia, nausea, dry mouth and dizziness.
- Reviews. A 2019 systematic review of ADHD with an anxiety disorder found only five eligible trials and said results pointed to more benefit with atomoxetine, while calling for larger studies. A 2025 review of adult ADHD with co-occurring conditions found medication reliably improved core ADHD symptoms, with more variable effects on the co-occurring conditions and some benefit for selected anxiety disorders.
The fair conclusion: medication can help some adults whose anxiety is driven partly by ADHD, can add anxiety for others, and the research cannot tell in advance which group a person is in. That is decided by careful follow-up.
Interactions with anxiety medications
Many adults with ADHD also take medication for anxiety or depression. Several label interactions apply:
- Amphetamines with SSRIs, SNRIs and other serotonergic drugs. Adderall XR, Vyvanse and other amphetamine labels warn that combining them raises the risk of serotonin syndrome, a potentially life-threatening reaction. The Adderall XR label says the combination should be used only if the potential benefit justifies the potential risk, with monitoring. Buspirone, also used for anxiety, is on the label's list of serotonergic drugs.
- Atomoxetine with paroxetine or fluoxetine. These SSRIs strongly inhibit the enzyme CYP2D6. The Strattera label reports that paroxetine raised atomoxetine exposure about 6.5-fold, and it adjusts dosing instructions when a strong CYP2D6 inhibitor is used.
- Viloxazine with duloxetine. Qelbree is contraindicated with sensitive CYP1A2 substrates, and its Medication Guide names duloxetine, an SNRI often used for anxiety, among them.
- MAOI antidepressants. The stimulant labels checked for this guide, and the Strattera and Qelbree labels, contraindicate use with an MAOI or within 14 days of stopping one.
More detail is in ADHD medication drug interactions. Give the prescriber and pharmacist a full list of everything you take, including supplements such as St. John's wort.
Other things that look like medication anxiety
- Caffeine. Stacking coffee or energy drinks on a stimulant can feel like anxiety. See ADHD medication and caffeine.
- Poor sleep. Insomnia is a common side effect, and short sleep makes worry worse. See ADHD medication and sleep.
- Wearing off. Some people feel edgy as a dose fades. See tolerance and wearing off.
- Mood changes. Irritability or agitation may belong with mood. See ADHD medication and mood changes and ADHD or bipolar disorder.
When to contact the prescriber, and when to get help now
- Contact the prescriber if anxiety, jitteriness or irritability is new or worse since starting or changing a medication, or if it is affecting work, sleep or relationships. Keep notes on timing: when you take the medication, when the anxiety starts and how long it lasts.
- Call the prescriber right away for panic attacks, severe agitation or new symptoms such as hearing or seeing things that are not real. Medication Guides ask patients to report new or worsening mental symptoms right away.
- Go to the emergency room for chest pain, shortness of breath or fainting, which stimulant Medication Guides say need care right away, and for possible serotonin syndrome (agitation, hallucinations, fast heartbeat, fever, sweating, tremor or muscle stiffness), especially after adding a serotonergic drug.
- Get urgent help for thoughts of suicide: call or text 988, or call 911 for immediate danger. Qelbree's boxed warning on suicidal thoughts applies to adults.
Make changes to any medication only with the prescriber. Anxiety on treatment can often be addressed, but the right step depends on your history and other medications.
Questions to bring
- Given my anxiety history, which options would you consider first, and why?
- How will you and I tell whether new anxiety comes from the medication, caffeine, sleep or something else?
- Does anything I already take for anxiety or depression interact with this medication?
- Who should manage my anxiety treatment alongside ADHD care?
Dr. Shershow provides ADHD evaluation and medication management when medication is appropriate, with follow-up visits by secure video. See adult ADHD treatment and side effects in adults.
Questions
Can Adderall or Vyvanse cause anxiety?
Yes, in some people. In the adult trials in their FDA labels, anxiety was reported by 8% of adults on Adderall XR (vs 5% on placebo) and 6% on Vyvanse (vs 0%). Most people in those trials did not report anxiety.
Can ADHD medication help anxiety?
For some people it may. A meta-analysis of 23 trials in children found less anxiety on stimulants than placebo, and an adult trial found atomoxetine improved both ADHD and social anxiety symptoms. Results vary between individuals.
Can I take an SSRI with ADHD medication?
Many people do, under a prescriber's supervision. Amphetamine labels warn about serotonin syndrome with SSRIs and SNRIs, and the Strattera label reports much higher atomoxetine levels with paroxetine or fluoxetine. Tell both prescribers about every medication you take.
Is anxiety a reason not to take a stimulant?
The current Concerta label does not list anxiety as a contraindication; it lists hypersensitivity and MAOI use. Whether a stimulant, a nonstimulant or no medication fits someone with anxiety is an individual decision with the prescriber.
How do I know if my anxiety is from ADHD medication?
Timing is the main clue, so track when you take the medication, when anxiety starts and how much caffeine and sleep you had. Anxiety disorders are common in adults with ADHD before treatment, so a pre-treatment baseline helps the prescriber sort it out.
Sources
- Kessler et al., American Journal of Psychiatry 2006;163(4):716-723: The prevalence and correlates of adult ADHD in the United States (National Comorbidity Survey Replication)
- DailyMed: Adderall XR (mixed amphetamine salts) extended-release capsules prescribing information and Medication Guide, Takeda (label effective April 30, 2026)
- DailyMed: Vyvanse (lisdexamfetamine dimesylate) prescribing information and Medication Guide, Takeda (label effective April 30, 2026)
- DailyMed: Concerta (methylphenidate hydrochloride) extended-release tablets prescribing information and Medication Guide, Janssen (label effective April 20, 2026)
- DailyMed: Strattera (atomoxetine) capsules prescribing information and Medication Guide, Eli Lilly (label effective June 30, 2026)
- DailyMed: Qelbree (viloxazine) extended-release capsules prescribing information and Medication Guide, Supernus (label effective October 5, 2026)
- Coughlin et al., Journal of Child and Adolescent Psychopharmacology 2015;25(8):611-617: Reduced risk of anxiety with psychostimulant treatment in children with ADHD (meta-analysis)
- Adler et al., Depression and Anxiety 2009;26(3):212-221: Atomoxetine treatment in adults with ADHD and comorbid social anxiety disorder
- Villas-Boas et al., International Clinical Psychopharmacology 2019;34(2):57-64: Pharmacological treatment of ADHD comorbid with an anxiety disorder (systematic review)
- Tripodi et al., Journal of Clinical Medicine 2025;14(24):8848: Effectiveness of pharmacological treatments for adult ADHD on psychiatric comorbidity (systematic review)
- 988 Suicide and Crisis Lifeline
